Home | Register | Login | Inquiries | Alerts | Sitemap |  


Advanced Search
JKM > Volume 36(1); 2015 > Article
Lee, Yang, and Chang: A Case Report on Two Psoriasis Patients with Insomnia

Abstract

Objectives:

The purpose of this study is to present two treatment cases of psoriasis with insomnia.

Methods:

We administered Guibi-tang medication to the psoriasis patients with insomnia and tested the results by Psoriasis Area and Severity Index (PASI) and Insomnia Severity Index (ISI) as well.

Results:

After the treatment both the patients showed improvements in PASI and ISI as well. PASI of Patient 1 changed from 15.2 to 1.2 along with the change of ISI from 27 to 2. In case of Patient 2, PASI changed from 14.6 to 1.8 while ISI changed from 21 to 6.

Conclusions:

The results suggest that Guibi-tang can be an effective treatment for insomnia and psoriasis as well. Further studies will be needed to demonstrate conclusively the effect of Guibi-tang on psoriasis cure.

Fig. 1.
before treatment (2013-11-11)
jkm-36-1-86f1.tif
Fig. 2.
after 18 days (2013-11-29)
jkm-36-1-86f2.tif
Fig. 3.
after 36 days (2013-12-17)
jkm-36-1-86f3.tif
Fig. 4.
after 86 days (2014-03-04)
jkm-36-1-86f4.tif
Fig. 5.
before treatment (2014-01-10)
jkm-36-1-86f5.tif
Fig. 6.
after treatment (2014-02-15)
jkm-36-1-86f6.tif
Table 1.
Variation of ISI Score
Before Treatment After 18 days After 36 days After 86 days
ISI Score 27 14 7 2
Table 2.
PASI Score of Case 1
Before Treatment After Treatment
Head 2×(3+3+3)×0.1=1.8 0×(0+0+0)×0.1=0
Trunk 2×(2+2+3)×0.3=4.2 1×(1+0+1)×0.3=0.6
Upper E. 2×(2+2+3)×0.2=2.8 1×(1+0+0)×0.2=0.2
Lower E. 2×(2+3+3)×0.4=6.4 1×(1+0+0)×0.4=0.4
PASI Score 15.2 1.2
Table 3.
Variation of ISI Score
Before Treatment After 25 days After 36 days
ISI Score 21 14 6
Table 4.
PASI Score of Case 2
Before Treatment After Treatment
Head 3×(2+2+2)×0.1=1.8 0×(0+0+0)×0.1=0
Trunk 2×(2+2+2)×0.3=3.6 1×(1+0+1)×0.3=0.6
Upper E. 2×(2+3+2)×0.2=2.8 1×(1+0+1)×0.2=0.4
Lower E. 2×(2+3+3)×0.4=6.4 1×(1+0+1)×0.4=0.8
PASI Score 14.6 1.8

참고문헌

1.. Andrew Warin. Psoriasis. Seoul: Academia;2005. 7–8. p. 102


2.. Kim SC, Ahn KJ, Hann SK, Kim JW, Sung KJ, Kye YC, et al. Clinico-Epidemiologic study on the Abuse, Misuse, and Adverse Effects of Topical Dermatologic Drugs. Korean J Dermal. 2003; 41:9. 1129–35.


3.. Lee JH. Updates on Biologics in the Management of Psoriasis. Journal of the Korean Society for Psoriasis. 2009; 6:1. 11


4.. Park YH, Cheong SH, Lee JS, Kim SS, Shin HD. A Literatural Study of Psoriasis. The journal of K.O.M.S. 1989; 9:1. 131–6.


5.. Kim NK, Hwang CY, Lim GS. The Oriental and Occidental bibliographic Study of Psoriasis. The Journal of Oriental Medical Surgery Ophthalmology & Otolaryngology. 1999; 12:1. 171


6.. Hong SH. Reviewing Research on Korean medical treatment of Psoriasis. The Journal of Korean Medical Ophthalmology & Otolaryngology & Dermatology. 2013; 26:4. 26–42.
crossref

7.. Yang JI, Lee KH, Kim YS, Shin MK, Yoo JH, Chang GT. A Report on Liver Function Tests of 82 Psoriasis Patients Taking Herbal Medication over 3 Months viewing Research on Korean medical treatment of Psoriasis. The Journal of Korean Oriental Medicine. 2012; 33:3. 95–104.


8.. Camila H, Mariana R, Mariana SA, Sergio T, Monica LA. Sleep Loss and Cytokines Levels in an Experimental Model of Psoriasis. 2012. 0051183Available at: URL:http://journalss.plos.org/article?id=10.1371/journal.pone.0051183. Accessed Oct. 15, 2014


9.. Jang JS, Jung IC, Lee SR. The Literature Review on th Etiologic Theory of Insomnia. Journal of Oriental Medical Academy in Daejeon University. 2014; 13:1. 341–342.


10.. The Compilation committee. Oriental Pathology. Seoul: Haneuimonhwasa;2007. p. 394–396.


11.. Cheng GP. Yixuexinwu. Seoul: Seowondang;1994. p. 224


12.. Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica. 1978; 157:4. 238–44.
crossref

13.. Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW. Cognitive behavior therapy and pharmacotherapy for insomnia. Arch InternMed. 2004; 164:1888–96.
crossref

14.. The Compilation committe. Dermatology. 4th ed.Seoul: Yeomungak;2002. p. 221–30.


15.. Kang WH. Atlas of Skin Disease. Seoul: Hanmibook;2003. p. 121


16.. Chao YF. Zhubingyuanhoulun. Seoul: Jungdam;1985. p. 461–2. p. 796–8.


17.. Park YG, Kim YK, Yun YG. A review on composition, action, compatibility of ingredients, clinical application of Gwibitang. The korean journal of oriental medical prescription. 2007; 15:2. 6


18.. Kim JH, Lee JK, Ha HK, Seo CS, Lee MY, Lee HY. Analysis of Studies on Guibi-tang (Guipitang) for Fundamental Establishment of Evidence Based Medicine (EBM). J of Oriental Neuropsychiatry. 2009; 20:3. 213


19.. Lee DJ, Kim SH. An Experimental Study on the Influence that the Medicinal Decoction of Kwi-Bi-Tang Affects Sleeping Hours and Sedation. K H Univ Med J. 1979; 2:1. 163–169.


Editorial office contact information
3F, #26-27 Gayang-dong, Gangseo-gu Seoul, 157-200 Seoul, Korea
The Society of Korean Medicine
Tel : +82-2-2658-3627   Fax : +82-2-2658-3631   E-mail : skom1953@daum.net
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Developed in M2PI